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Abstract
Objective: This study investigated whether the Health Assessment Questionnaire (HAQ) can be used as an instrument to
assess the need for social support measures that address activity limitations and participation issues in patients with
rheumatoid arthritis (RA).
Methods: This multicenter observational study included patients with RA and disease duration of at least one year,
consulting their rheumatologist for routine evaluation of disease activity. In the single study visit data on demographics,
disease history and current treatment were collected. DAS28 values were collected to evaluate current RA disease activity.
Patients were asked to fill out the HAQ and SF-36 questionnaires. Receiver Operator Characteristics (ROC) curves were
constructed to evaluate the performance of the HAQ, SF-36 and DAS28 in predicting the need for nine supporting measures
available for chronically ill patients in the Belgian social security system. The expert opinion of the treating rheumatologist
was used as a reference.
Results: The study included 316 patients with a mean age of 59.8612.6 years, disease duration of 11.469.3 years, mean
DAS28 values of 2.8361.17. Mean HAQ score was 0.9560.73, mean SF-36 score 56.5621.3. HAQ scores.1 were observed in
39.4% of patients. The area under the HAQ ROC curve was consistently .0.7 and higher for the HAQ than for SF-36 or
DAS28 for all support measures. Rheumatologists on average recommended 3.67 support measures.
Conclusion: The HAQ score was found to be a good predictor of the need for social support measures in patients with RA.
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Introduction
As a chronic inflammatory disease, rheumatoid arthritis (RA)
can lead to impairment of physical functioning and mobility, loss
of productivity, and difficulties in performing normal daily
activities. Patients with RA are confronted with extra costs to
compensate for these difficulties, as well as with extra health care
costs, often in combination with loss of income [1,2].
To limit the impact of RA on functioning and quality of life,
support measures addressing activity limitations and participation
issues are an important complement to the medical treatment. In
order to promote equitable allocation of supporting measures and
determine the level and type of supporting measures needed,
objective and reliable evaluation of the level and area of activity
limitations in patients is essential.
The Health Assessment Questionnaire (HAQ) was developed
three decades ago at Stanford University by Fries and colleagues
as a patient-reported outcome instrument designed to measure
health status and health-related quality of life. It is a 20-item
questionnaire covering activities of daily living in 8 domains.
Respondents indicate for every item whether they can do the
activity ‘without any difficulty’, with ‘some’ or ‘much difficulty’ or
are ‘unable to do’ the activity. The HAQ yields a disability index
(HAQ-DI) score between 0 and 3, where 0 means no disability and
3 represents total dependence on others [3–5]. HAQ scores .1
are considered to indicate the presence of disability.
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The HAQ is one of the most important patient-reported
outcome measures in RA clinical trials, but is also commonly used
by rheumatologists in daily practice [6,7], to assess the functional
status of their patients. The HAQ has been translated in many
languages [8] and has proven validity and reliability in patients
with RA [9,10].
In the Belgian social security system, nine different social
support measures are currently available for persons with chronic
daily activity limitations and loss of autonomy, to promote their
reintegration and participation. These support measures comprise
financial benefits, disease cost reduction measures, tax benefits and
social benefits (see Table 1). There is no validated score for
allocation of these benefits.
In this study, we investigated whether the HAQ can predict the
need for such social support measures in patients with RA, with
the expert opinion of the treating rheumatologist as a reference
and compared the performance of HAQ, DAS28 and SF-36.
Patients and Methods
Ethics Statement
All patients gave written informed consent and the study was
approved by the Ethics Committee of the University Hospital
Ghent (ref. 2010-094) and the ethical committees of the
participating clinical centers.
Study Design
Patients eligible for inclusion in this multicenter observational
study were at least 18 years of age, met the American College of
Rheumatology (ACR) classification criteria for RA [11], had a
disease duration of at least one year and consulted their
rheumatologist for routine half-yearly outpatient evaluation
(according to nomenclature number 478030 of the Belgian social
security system). No specific exclusion criteria were defined.
To obtain a representative population of patients with RA,
participating rheumatologists asked the first eligible patient in
every consultation time block to participate in the study. Patients
who gave their written informed consent were included in the
study and proceeded with the study data collection in the same
visit.
Data collected comprised patient demographics, disease history,
current treatment, DAS28, HAQ and SF-36 questionnaires. The
treating rheumatologists scored the need for each of 9 different
supporting measures (Table 1) available for chronically ill patients
in the Belgian social security system on a four item categorical
scale as: certainly needed, probably needed, probably not needed
or certainly not needed. HAQ and SF-36 questionnaires were
filled out independently by the patient; the rheumatologists were
unaware of the SF-36 or HAQ scores, which were only calculated
during data analysis.
Data analysis and statistics
Data are presented as mean 6 standard deviation for normally
distributed variables, as median (range) for variables not following
a normal distribution or as percentages. Statistical analysis was
performed with SPSS version 20 software (IBM Corporation,
Armonk, New York, USA). A p-value ,0.05 was considered
statistically significant.
The Kolmogorov-Smirnov test was used to assess the normal
distribution of variables. To compare age groups ,65 y versus $
65 y, unpaired t-test or Mann-Whitney U-test was used for
continuous variables, and chi-square test for categorical variables.
To evaluate the performance of the HAQ, SF-36 and DAS28 as
tests to predict the need for social support measures by patients
with RA, Receiver Operator Characteristics (ROC) curves were
constructed and the area under the ROC curve (AUC) was
calculated [12], with the recommendation of the treating
rheumatologist for all nine support measures (Table 1) as the
reference. To this end, the scores ‘certainly needed’ and ‘probably
needed’ were considered as a positive recommendation for a
particular support measure, unless otherwise stated. For the
purpose of constructing the ROC-curve with sensitivity and
specificity for the outcome that at least one support measure is
considered necessary by the treating rheumatologist, only the score
‘certainly needed’ was considered as a positive score. The
relevance of such exercise is that a cut-off for this criterium could
define a subpopulation of RA patients who would certainly need at
least one support measure and a complimentary subpopulation in
which no essential support measures apply.
The AUCs of the ROC curves for HAQ, SF-36 and DAS28
were compared using ANOVA.
Table 1. Social support measures for chronically ill patients in Belgium.
Support measure Type Description
Integration allowance Financial benefit (,65 years) To compensate extra costs due to diminished autonomy and to enhance social participation
of person with special needs.
Allowance for help to the aged Financial benefit (.65 years) For seniors with chronic health disorders confronted with supplementary costs due to loss
of autonomy, in order to enhance their social participation.
Tax reduction Tax benefit Income tax exemption for families with one or more disabled persons.
Parking card Promotion of mobility For persons with mobility restrictions. Allows parking in parking places reserved for disabled
persons and parking without time limit in areas of time restricted parking.
Vehicle tax waiver Tax benefit Exemption of car tax for disabled persons
Free public transportation for
attendant
Promotion of mobility Free public transportation access for companions of people with mobility restrictions who
can’t travel alone
Social telephone rate Cost reduction Reduced telephone connection rate, subscription fee and call charges for people with
functional limitations.
Social rate utility services Cost reduction Exemption of regular allowance and free delivery of a fixed amount of gas and electricity for
disabled persons.
Allowance for chronic illness Financial benefit (,65 years) Premium for persons with a chronic disease confronted with high medical costs.
doi:10.1371/journal.pone.0106749.t001
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The Youden index (sensitivity + specificity – 1) was used to
provide a single statistic to capture the performance of the
predictive tests [13].
Results
Population characteristics
Table 2 summarizes the study population characteristics. The
study included 316 patients with RA. Patients were on average
59.8612.6 years old, with 36.7% (n= 116) of patients aged 65 or
older, 69.9% were female. Mean disease duration was 11.469.3
years, rheumatoid factor was present in 72.9% of patients and
anti-CCP in 58.7%. DAS28 values were 2.8361.17, HAQ scores
were 0.9560.73 and 39.4% of patients had a HAQ score .1. SF-
36 scores were 56.5621.3, with lower scores on the physical than
on the mental subscale, suggesting a larger impact of RA on
physical than on mental functioning. HAQ scores and DAS28
values did not differ significantly between patients below 65 years
of age and older patients, but patients aged 65 or older had
significantly higher SF-36 scores (Figure 1A).
Current RA treatment included DMARDs in 86.4% of patients,
45.9% of patients were on biologicals. Corticosteroids were used
by 44.6% and NSAIDs by 42.2% of patients.
Assessment of the need for social support measures by
the rheumatologist
The need for the social support measures listed in Table 1 was
scored for every patient by the rheumatologist as certainly or
probably needed or certainly or probably not needed. Rheuma-
tologists on average recommended 3.67 support measures per
patient.
The most frequently recommended support measures were the
allowance for chronic illness (62.2%), tax reduction (51.5%) and
social telephone rate (49.5%). Integration allowance was recom-
mended for 43.6% of patients,65 years of age, allowance for help
to the aged was recommended for 48.6% of patients older than 65.
Rheumatologists recommended the social rate for utility services in
42.2% of patients. Vehicle tax waiver, parking card and free public
transportation for an attendant were recommended for respec-
tively 45.6%, 37.8% and 26.9% of patients. (Figure 2).
Predicting the need for social support measures
The number of benefits recommended by the rheumatologist
clearly increased with increasing HAQ scores, but not with
increasing DAS28 values. Likewise, the number of benefits
recommended did not increase with decreasing SF-36 scores
(Figure 1B).
In order to assess whether measures of disease activity or
functioning can predict the need for social support measures,
ROC curve analysis was performed with HAQ, SF-36 and DAS28
for each of the social support measures, with the recommendation
of the rheumatologist as reference or gold standard.
The AUC of these ROC curves are presented in Table 3. For
all support measures, AUCs were significantly higher for the HAQ
than for either SF-36 or DAS28, with AUC values for HAQ of at
least 0.7 for all measures (ANOVA, p= 0.001), indicating that the
HAQ score is a valuable predictor of the need for social support
measures in patients with RA and is superior in that function to
Table 2. Population characteristics.
Population characteristics Overall ,65 y $65 y
Nr of patients 316 200 116
% of patients 100 63.3 36.7
Age (y) 59.8612.6 52.669.9 72.3165.4
Gender ratio (% female) 69.9 73.5 63.8
RA characteristics
Disease duration (y) 11.469.3 10.868.98 12.269.8
RF (% positive) 72.9 71.5 75.2
Anti-CCP (% positive) 58.7 60.5 55.6
Erosions (% positive) 65.5 65.3 66.0
DAS 28 2.8361.17 2.8961.16 2.7161.18
HAQ 0.9560.73 0.9160.68 1.0160.81
% HAQ .1 39.4 37.0 42.2
SF-36 Total 56.5621.3 54.0620.8 60.9621.6
MCS 60.6621.6 58.2621.4 64.7621.2
PCS 49.4621.4 47.02620.9 53.6621.6
Treatment (% of patients)
DMARDs 86.4 86.0 87.1
DMARDs – no biologicals 51.6 45.5 62.1
Biologicals 45.9 52.5 34.5
Corticosteroids 44.6 56.5 46.6
NSAIDs 42.2 44.5 38.4
Data are expressed as mean 6 standard error or as percentages. Abbreviations: CRP: C-reactive protein, DAS28: disease activity score using 28 joint counts, DMARDs:
Disease-modifying anti-rheumatic drugs, HAQ: Health Assessment Questionnaire, MCS: mental component summary, NSAIDs: non-steroidal anti-inflammatory drugs, PCS:
physical component summary, SF-36: Short Form-36.
doi:10.1371/journal.pone.0106749.t002
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Figure 1. HAQ, SF-36 and DAS 28. A. In function of patient age category. Means for HAQ and DAS28 did not differ between patients below 65 y of
age and patients of 65 or older, but patients in the latter age category had significantly higher SF-36 scores *: p,0.05 (t-test, error bars represent
standard error of the mean). B. In function of number of benefits recommended by the rheumatologist. (Error bars represent standard error of themean).
doi:10.1371/journal.pone.0106749.g001
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DAS28 and SF-36. Figure 3 shows the ROC curves of the HAQ
as predictor for the need for support measures. See File S1 for the
raw data for these ROC curves.
An additional purpose was to create a ROC-curve with
sensitivity and specificity for the outcome that at least one support
measure is considered certainly necessary by the treating
rheumatologist. In this way, one can propose a cut-off to define
a subpopulation of RA patients who would certainly need at least
one support measure and a complimentary subpopulation in
which no essential support measures apply. Thus, in the latter
subpopulation with a score beneath such cut-off, one would not
miss any essential support measure. The AUC for such ROC-
curve with HAQ, SF-36 and DAS28 was respectively 0.750, 0.698
and 0.656. For the HAQ, the Youden Index for this analysis
reached a maximum of 0.391 for a HAQ cut-off of 0.69 (sensitivity
80.8% and specificity 58.3%). In our study population, 133
patients (42.1%) had a HAQ score below 0.69.
No support measures were recommended by the rheumatologist
in 24.4% of patients overall and in 43.3% of patients with a HAQ
score below 0.69.
Discussion
Optimal care for patients with RA needs to include support
measures to compensate for difficulties in performing daily
activities and participation issues. Together, they may alleviate
the substantial impact this disease may have.
In this study we evaluated whether disease activity parameters
such as DAS28, indicators of functioning such as HAQ, or a
measure of health status like SF-36 can predict the need for social
support measures, since equitable allocation of benefits requires a
reliable measure to evaluate activity limitation.
In this representative, unselected population of patients with
longstanding RA, the HAQ score was found to be the best
predictor for the need of social support measures, with AUC of the
ROC curve of at least 0.7 for all support measures investigated.
Figure 2. Assessment of need for social support measures by the rheumatologist. Data are expressed as percentage of patients. For
support measures with age limits, the patient percentage refers only to the patients in the age category eligible to receive the benefit.
doi:10.1371/journal.pone.0106749.g002
Table 3. AUC of ROC- curves for HAQ, SF-36 and DAS28.
HAQ SF-36 SF-36 PCS DAS28
Integration allowance (,65 y) 0.806 0.725 0.779 0.695
Allowance for help to the aged (.65 y) 0.798 0.798 0.776 0.785
Tax reduction 0.766 0.727 0.748 0.713
Parking card 0.831 0.728 0.750 0.703
Vehicle tax waiver 0.778 0.710 0.715 0.632
Free public transportation for attendant 0.700 0.642 0.650 0.660
Social telephone rate 0.775 0.708 0.721 0.665
Social rate utility services 0.755 0.735 0.748 0.647
Allowance for chronic illness 0.707 0.639 0.657 0.641
Areas under the curve (AUC) of the ROC curve analysis performed with HAQ, SF-36, SF-36 physical component score (PCS) and DAS28 for the social support measures
available in Belgium in order to assess whether these instruments can be used to predict the need for social support measures in patients with RA. The recommendation
of the rheumatologist was used as reference.
doi:10.1371/journal.pone.0106749.t003
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Figure 3. ROC curves for HAQ predicting the need for different social support measures. Receiver operator characteristic analysis (ROC)
demonstrates that the Health Assessment Questionnaire (HAQ) performs well as a tool to predict the need for social support measures in patients
with RA. The recommendation by the treating rheumatologist was used as reference.
doi:10.1371/journal.pone.0106749.g003
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Previous studies in the United Kingdom (UK) showed that the
HAQ can be used to predict successful application for access to
benefits and financial support [14–16]. In the UK, 69% of the
patients with RA or osteoarthritis of hip or knee and a HAQ score
.1.5 who applied were awarded the benefit [15].
In our study, no data were collected on actual applications to
receive the social support measures studied, nor on actual
allocation of these benefits, so that the results of our study solely
represent the expert opinion of the treating rheumatologists on
their patients’ needs. We did not attempt to calculate HAQ cut-off
values for the different support measures investigated, but instead
chose to include the raw data of the ROC curves as supplementary
data (File S1). Consequently, the data from this study can be used
to calculate HAQ cut-offs to suit the sensitivity or specificity limits
one wishes to use or to fit the budget available for these benefits.
Based upon our analysis, we propose a HAQ cut-off value of
0.69 to define two RA subpopulations according to whether or not
these patients absolutely require at least one of the described
support measures. The relevance of this cut-off could be that in
case the HAQ score is lower than this cut-off, one could justify not
pursuing further efforts for allocation of support measures.
Functioning may be further impaired by factors such as age and
comorbidity. It is an important strength of the HAQ to provide a
comprehensive assessment of a patient’s functioning, not only
determined by RA, but also by old age or limitations as a
consequence of superimposed comorbidity. The need of support
measures will increase with this global loss of functioning and not
just with the functional limitations of RA.
We did not collect socioeconomic parameters or educational
status in this study. The impact of these parameters on functioning
are still controversial: a Swedish cross sectional study reported no
influence of socioeconomic factors and education on disability in
RA patients [17] but a number of studies have found RA disease
activity and severity to be more pronounced in patients with lower
socio-economic status [18,19].
Our findings indicate that it would be feasible to expand the
scope of application of the HAQ to include its use as an instrument
for allocating access to financial or social support measures or to
tax benefits for patients with RA. Such an approach would have
the added benefit of reducing the administrative burden involved
with benefit allocation by using the results of a test that is widely
used and accepted for clinical monitoring of patients with RA.
Additional research is needed to investigate whether the use of
HAQ score to determine the need of support can be generalized to
other regions, with other types of support measures available, and
to determine what the impact would be of using the HAQ for the
actual allocation of social support measures. A follow-up study
investigating which domains of the HAQ determine best the need
for which kind of support measures is currently ongoing.
In summary, the HAQ score was found to be a good predictor
(better than DAS28 and SF-36) for the need for social support
measures in patients with RA, as assessed by the rheumatologist.
Supporting Information
File S1 ROC curve data tables for the HAQ. Tables with
coordinates of the ROC curve analysis investigating the
performance of the Health Assessment Questionnaire (HAQ) as
an instrument to evaluate the need for social support measures in
patients with RA. The expert opinion of the treating rheumatol-
ogist on the need for social support measures was used as a
reference.
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